Home/Filings/4/0001104659-20-056351
4//SEC Filing

Schranz Jennifer 4

Accession 0001104659-20-056351

CIK 0001641640other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 6:32 PM ET

Size

4.5 KB

Accession

0001104659-20-056351

Insider Transaction Report

Form 4
Period: 2020-04-30
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-04-30$0.55/sh301$165169,347 total

Documents

1 file

Issuer

Nabriva Therapeutics plc

CIK 0001641640

Entity typeother

Related Parties

1
  • filerCIK 0001735382

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 6:32 PM ET
Size
4.5 KB